Three new cancer drugs could help AstraZeneca make a dent in its lofty ambition to become an $80 billion company by 2030.

After rapid expansion, signs of a slowdown raise questions about future opportunities in the sector When it emerged that ...

An colon cancer study highlighted the importance of the National Cancer Institute, while cancer doctors got a look at a ...

DHR and AstraZeneca team up to develop AI-powered diagnostics, aiming to boost precision medicine by improving patient ...

But private sector companies like AstraZeneca are pushing forward with major investments in life sciences research and manufacturing. The Cambridge, U.K.-based pharmaceutical giant on Monday ...

CAMBRIDGE, Britain (AP) — CAMBRIDGE, Britain (AP) — Astrazeneca PLC (AZN) on Tuesday reported first-quarter profit of $2.92 billion. On a per-share basis, the Cambridge, Britain-based company ...

AstraZeneca ... inside a patient’s body. Under acquisition terms announced Monday, AstraZeneca will pay $425 million up front for all outstanding equity of privately held EsoBiotec. The ...

The boss of drugmaker AstraZeneca was handed a pay package worth nearly £15 million last year, new company accounts reveal. The Cambridge-based pharmaceutical company behind a variety of medicines ...

The Cambridge-based pharmaceutical company behind a variety of medicines paid its chief executive Pascal Soriot £14.7 million in 2024. The chief executive of drugmaker AstraZeneca was handed a pa ...

A few weeks later, Donelan was invited to visit AstraZeneca’s research and development site in Cambridge, the heartland of Britain’s life sciences sector, where she was treated to a glitzy ...

In a speech earlier this week which named AstraZeneca, the chancellor said life sciences would be key to boosting the economy. She announced plans to deliver an Oxford-Cambridge growth corridor ...